Dicker DT - Search Results

1

Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.

Prabhu VV, Talekar MK, Lulla AR, Kline CLB, Zhou L, Hall J, Van den Heuvel APJ, Dicker DT, Babar J, Grupp SA, Garnett MJ, McDermott U, Benes CH, Pu JJ, Claxton DF, Khan N, Oster W, Allen JE, El-Deiry WS. Prabhu VV, et al. Among authors: dicker dt. Cell Cycle. 2018;17(4):468-478. doi: 10.1080/15384101.2017.1403689. Epub 2018 Feb 19. Cell Cycle. 2018. PMID: 29157092 Free PMC article.

2

Repression of BRCA1 through a feedback loop involving p53.

MacLachlan TK, Dash BC, Dicker DT, El-Deiry WS. MacLachlan TK, et al. Among authors: dicker dt. J Biol Chem. 2000 Oct 13;275(41):31869-75. doi: 10.1074/jbc.M003338200. J Biol Chem. 2000. PMID: 10884389 Free article.

3

The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.

Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS. Ozoren N, et al. Among authors: dicker dt. Cancer Res. 2000 Nov 15;60(22):6259-65. Cancer Res. 2000. PMID: 11103780

4

Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines.

Kim K, Takimoto R, Dicker DT, Chen Y, Gazitt Y, El-Deiry WS. Kim K, et al. Among authors: dicker dt. Int J Oncol. 2001 Feb;18(2):241-7. doi: 10.3892/ijo.18.2.241. Int J Oncol. 2001. PMID: 11172588

5

Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling.

McDonald ER 3rd, Chui PC, Martelli PF, Dicker DT, El-Deiry WS. McDonald ER 3rd, et al. Among authors: dicker dt. J Biol Chem. 2001 May 4;276(18):14939-45. doi: 10.1074/jbc.M100399200. Epub 2001 Feb 13. J Biol Chem. 2001. PMID: 11279061 Free article.

6

The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.

Takimoto R, Wang W, Dicker DT, Rastinejad F, Lyssikatos J, el-Deiry WS. Takimoto R, et al. Among authors: dicker dt. Cancer Biol Ther. 2002 Jan-Feb;1(1):47-55. doi: 10.4161/cbt.1.1.41. Cancer Biol Ther. 2002. PMID: 12174820 Free article.

7

Enhanced sensitivity of G1 arrested human cancer cells suggests a novel therapeutic strategy using a combination of simvastatin and TRAIL.

Jin Z, Dicker DT, El-Deiry WS. Jin Z, et al. Among authors: dicker dt. Cell Cycle. 2002 Jan;1(1):82-9. Cell Cycle. 2002. PMID: 12429913

8

The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression).

Sax JK, Dash BC, Hong R, Dicker DT, El-Deiry WS. Sax JK, et al. Among authors: dicker dt. Cell Cycle. 2002 Jan;1(1):90-6. Cell Cycle. 2002. PMID: 12429914

9

Flow cytometric analysis of cell cycle control by tumor suppressor genes.

Dicker DT, El-Deiry WS. Dicker DT, et al. Methods Mol Biol. 2003;223:211-5. doi: 10.1385/1-59259-329-1:211. Methods Mol Biol. 2003. PMID: 12777732 No abstract available.

10

Flow cytometric analysis of tumor suppressor gene-induced apoptosis.

Dicker DT, El-Deiry WS. Dicker DT, et al. Methods Mol Biol. 2003;223:271-82. doi: 10.1385/1-59259-329-1:271. Methods Mol Biol. 2003. PMID: 12777737 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters